$RARE Cashflow Statement | Understand Stock

$RARE

$16.75 +$0.67 (4.17%) Close

$RARE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Acquired in-process research and development
Amortization of discount on marketable securities, net
Depreciation and amortization
Change in fair value of equity investments
Non-cash collaboration royalty revenue
Non-cash royalty revenue
Non-cash interest expense on liabilities for sales of future royalties
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Other assets
Accounts payable, accrued, and other liabilities
Contract liabilities, net
Deferred tax liabilities
Net cash used in operating activities
Investing activities:
Purchase of property, plant, and equipment
Acquisition, net of cash acquired
Purchase of marketable securities
Purchase of equity investments
Proceeds from sale of marketable securities
Proceeds from sale of equity investments
Proceeds from maturities of marketable securities
Payments for intangible asset
Other
Net cash provided by (used in) investing activities

Financing activities:
Proceeds from the sale of future royalties, net
Proceeds from the issuance of common stock in connection with underwritten public offerings, net
Proceeds from the issuance of common stock in connection with the license agreement, net
Proceeds from the issuance of common stock and pre-funded warrants in connection with underwritten public offerings, net
Proceeds from the issuance of common stock in connection with at-the-market offering, net of issuances costs
Proceeds from the issuance of common stock in connection with at-the-market offering, net
Proceeds from the issuance of common stock under equity plans, net
Proceeds from issuance of equity from noncontrolling interest
Other
Net cash provided by financing activities

Effect of exchange rate changes on cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Supplemental disclosures of non-cash information:
Stock-based compensation capitalized into ending inventory
Acquired lease liabilities arising from obtaining right-of-use assets and property, plant, and equipment
Non-cash interest expense on liabilities for sales of future royalties capitalized during the year into ending property, plant and equipment
Costs of intangible assets included in accounts payable, accrued and other liabilities

Comments